Intracoronary brachytherapy in the treatment of in-stent restenosis. Initial experience in Brazil
AUTOR(ES)
Brito Jr, Fábio Sândoli de, Hanriot, Rodrigo, Almeida, Breno Oliveira, Rati, Miguel Antonio Neves, Medeiros, Nadia Sueli de, Lagatta, Mônica, Cruz, José Carlos da, Salvajoli, João Victor, Perin, Marco Antonio
FONTE
Arquivos Brasileiros de Cardiologia
DATA DE PUBLICAÇÃO
2001-09
RESUMO
Intracoronary brachytherapy using beta or gamma radiation is currently the most efficient type of therapy for preventing the recurrence of coronary in-stent restenosis. Its implementation depends on the interaction among interventionists, radiotherapists, and physicists to assure the safety and quality of the method. The authors report the pioneering experience in Brazil of the treatment of 2 patients with coronary in-stent restenosis, in whom beta radiation was used as part of the international multicenter randomized PREVENT study (Proliferation REduction with Vascular ENergy Trial). The procedures were performed rapidly and did not require significant modifications in the traditional techniques used for conventional angioplasty. Alteration in the radiological protection devices of the hemodynamic laboratory were also not required, showing that intracoronary brachytherapy using beta radiation can be incorporated into the interventional tools of cardiology in our environment.
Documentos Relacionados
- Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis: Immediate and Late Results
- A Potential Complication of Directional Coronary Atherectomy for In-Stent Restenosis
- Effects of stent sizing on endothelial and vessel wall stress: potential mechanisms for in-stent restenosis
- Mechanisms of restenosis.
- "Análise volumétrica da hiperplasia intimal intra-stent em pacientes diabéticos tratados com e sem abciximab"